XML 22 R76.htm IDEA: XBRL DOCUMENT v2.4.0.6
Note 16 - Condensed Consolidating Financial Information Of Guarantor Subsidiary (Detail) - Condensed Consolidating Cash Flow Information (USD $)
In Thousands, unless otherwise specified
3 Months Ended 6 Months Ended
Aug. 19, 2011
Nov. 30, 2011
Nov. 30, 2012
May 31, 2012
May 31, 2011
Net cash provided by (used in) operating activities $ 25,588 $ 1,883 $ 8,550    
Net cash used in investing activities (2,265) (1,941,900) (4,028)    
Net cash provided by ( used in) financing activities 66 1,655,165 (4,383)    
Effect of exchange rate changes on cash and cash equivalents (3,029) (1,236) 296    
Increase (decrease) in cash and cash equivalents 20,360 (286,088) 435    
Cash and cash equivalents 322,963 36,875 19,013 18,578 302,603
Immucor Inc [Member] | Beginning Balance [Member]
         
Cash and cash equivalents 250,386 314,304 8,093    
Immucor Inc [Member] | Ending Balance [Member]
         
Cash and cash equivalents 314,304 26,806 1,146    
Immucor Inc [Member]
         
Net cash provided by (used in) operating activities 64,243 (1,664) (142)    
Net cash used in investing activities (393) (1,941,000) (2,422)    
Net cash provided by ( used in) financing activities 68 1,655,166 (4,383)    
Increase (decrease) in cash and cash equivalents 63,918 (287,498) (6,947)    
Cash and cash equivalents     1,146 8,093  
Guarantor [Member] | Beginning Balance [Member]
         
Cash and cash equivalents (80) (89) (144)    
Guarantor [Member] | Ending Balance [Member]
         
Cash and cash equivalents (89) (89)      
Guarantor [Member]
         
Net cash provided by (used in) operating activities 144 199 1,748    
Net cash used in investing activities (153) (199) (1,604)    
Increase (decrease) in cash and cash equivalents (9)   144    
Non-Guarantors [Member] | Beginning Balance [Member]
         
Cash and cash equivalents 52,297 8,748 10,629    
Non-Guarantors [Member] | Ending Balance [Member]
         
Cash and cash equivalents 8,748 10,158 17,960    
Non-Guarantors [Member]
         
Net cash provided by (used in) operating activities (13,821) 13,581 6,852    
Net cash used in investing activities (1,719) (701) (2)    
Net cash provided by ( used in) financing activities (25,085) (10,753)      
Effect of exchange rate changes on cash and cash equivalents (2,924) (717) 481    
Increase (decrease) in cash and cash equivalents (43,549) 1,410 7,331    
Cash and cash equivalents     17,960 10,629  
Intersegment Elimination [Member] | Ending Balance [Member]
         
Cash and cash equivalents     (93)    
Intersegment Elimination [Member]
         
Net cash provided by (used in) operating activities (24,978) (10,233) 92    
Net cash provided by ( used in) financing activities 25,083 10,752      
Effect of exchange rate changes on cash and cash equivalents (105) (519) (185)    
Increase (decrease) in cash and cash equivalents     (93)    
Cash and cash equivalents     (93) (144)  
Total [Member] | Beginning Balance [Member]
         
Cash and cash equivalents 302,603 322,963 18,578    
Total [Member] | Ending Balance [Member]
         
Cash and cash equivalents 322,963 36,875 19,013    
Total [Member]
         
Net cash provided by (used in) operating activities 25,588 1,883 8,550    
Net cash used in investing activities (2,265) (1,941,900) (4,028)    
Net cash provided by ( used in) financing activities 66 1,655,165 (4,383)    
Effect of exchange rate changes on cash and cash equivalents (3,029) (1,236) 296    
Increase (decrease) in cash and cash equivalents 20,360 (286,088) 435    
Cash and cash equivalents     $ 19,013 $ 18,578